Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.0044 | 0.0117 | 0.0001 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0124 | 0.3067 | 0.2985 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.6063 | 0.6063 |
Trichomonas vaginalis | AGC family protein kinase | 0.0124 | 0.3067 | 0.2728 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.0311 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0044 | 0.0117 | 0.0117 |
Schistosoma mansoni | protein kinase | 0.0124 | 0.3067 | 0.3067 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0156 | 0.4257 | 0.4189 |
Echinococcus multilocularis | dual specificity serine:threonine tyrosine | 0.0311 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0124 | 0.3067 | 0.7125 |
Echinococcus granulosus | serine:threonine protein kinase Chk2 | 0.0044 | 0.0117 | 0.0001 |
Echinococcus multilocularis | geminin | 0.0205 | 0.6063 | 0.6017 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0156 | 0.4257 | 0.4257 |
Loa Loa (eye worm) | AUR protein kinase | 0.0124 | 0.3067 | 0.3067 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0156 | 0.4257 | 0.4257 |
Echinococcus multilocularis | Serine:threonine protein kinase PLK4 | 0.0123 | 0.3041 | 0.2959 |
Brugia malayi | Cytochrome P450 family protein | 0.006 | 0.0693 | 0.0693 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0156 | 0.4257 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0311 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0706 | 0.0706 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0311 | 1 | 1 |
Schistosoma mansoni | kinase | 0.0225 | 0.6832 | 0.6832 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.6063 | 0.6063 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0156 | 0.4257 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Entamoeba histolytica | protein kinase , putative | 0.0124 | 0.3067 | 0.7125 |
Echinococcus granulosus | Serine:threonine protein kinase PLK4 | 0.0123 | 0.3041 | 0.2959 |
Trichomonas vaginalis | AGC family protein kinase | 0.0124 | 0.3067 | 0.2728 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0706 | 0.0706 |
Giardia lamblia | Kinase, TTK | 0.0311 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Echinococcus granulosus | aurora kinase A | 0.0124 | 0.3067 | 0.2985 |
Brugia malayi | serine/threonine kinase 12 | 0.0124 | 0.3067 | 0.3067 |
Trypanosoma brucei | polo-like protein kinase | 0.0156 | 0.4257 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.6063 | 0.6017 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0124 | 0.3067 | 0.3067 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0156 | 0.4257 | 1 |
Echinococcus multilocularis | aurora kinase A | 0.0124 | 0.3067 | 0.2985 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0156 | 0.4257 | 0.4189 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0124 | 0.3067 | 0.7125 |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0124 | 0.3067 | 0.2985 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0706 | 0.0706 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0124 | 0.3067 | 0.3067 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0124 | 0.3067 | 0.5 |
Echinococcus granulosus | dual specificity serine:threonine tyrosine | 0.0311 | 1 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0124 | 0.3067 | 0.7125 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0706 | 0.0706 |
Loa Loa (eye worm) | AUR protein kinase | 0.0124 | 0.3067 | 0.3067 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0124 | 0.3067 | 0.7125 |
Trichomonas vaginalis | AGC family protein kinase | 0.0124 | 0.3067 | 0.2728 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0156 | 0.4257 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0124 | 0.3067 | 0.7125 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0124 | 0.3067 | 0.3067 |
Loa Loa (eye worm) | AUR protein kinase | 0.0124 | 0.3067 | 0.3067 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.006 | 0.0693 | 0.0693 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0156 | 0.4257 | 0.4257 |
Trichomonas vaginalis | AGC family protein kinase | 0.0124 | 0.3067 | 0.2728 |
Toxoplasma gondii | aurora kinase | 0.0124 | 0.3067 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Schistosoma mansoni | dual specificity serine/threonine tyrosine kinase | 0.0311 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0124 | 0.3067 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0156 | 0.4257 | 0.3976 |
Giardia lamblia | Kinase, PLK | 0.0156 | 0.4257 | 0.1716 |
Loa Loa (eye worm) | TTK protein kinase | 0.0311 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0124 | 0.3067 | 0.7125 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | > 53 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for small molecule agonists of the CRF-binding protein and CRF-R2 receptor complex. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | > 47.1 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for small molecule antagonists of the CRF-binding protein and CRF-R2 receptor complex. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.1836 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.